Due to the recent hurricane we are going to postpone tomorrow's MD STARnet webinar.
We will be in touch regarding the new date. Sorry for the inconvenience.
Added by PPMD on October 30, 2012 at 1:00pm — No Comments
New release from Prosensa:
£10m in milestone payments received from GlaxoSmithKline
Leiden, The Netherlands, 23 October 2012 – Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, has selected clinical candidates for two more compounds for the treatment of Duchenne muscular dystrophy (DMD) and has been granted…Continue
Dr. Jerry Mendell, Director of the Centers for Gene Therapy and Muscular Dystrophy at Nationwide Children's Hospital and principal investigator of the Phase IIb eteplirsen study, presented the full set of 48-week data from…Continue
Added by PPMD on October 16, 2012 at 9:00am — No Comments